SHE:300016 Revenue

Beijing Beilu Pharmaceutical had revenue of 301.53M CNY in the quarter ending June 30, 2025, with 13.18% growth. This brings the company's revenue in the last twelve months to 1.09B, up 18.05% year-over-year. In the year 2024, Beijing Beilu Pharmaceutical had annual revenue of 983.55M with 10.42% growth.

Revenue (ttm)

1.09B

Revenue Growth

+18.05%

P/S Ratio

4.43

Revenue / Employee

932.51K

Employees

1,173

Market Cap

4.84B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	983.55M	92.84M	10.42%
Dec 31, 2023	890.72M	124.84M	16.30%
Jan 1, 2023	765.88M	-94.02M	-10.93%
Jan 1, 2022	859.91M	32.57M	3.94%
Dec 31, 2020	827.34M	8.22M	1.00%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Huadong Medicine	42.62B
WuXi AppTec	41.90B
Yunnan Baiyao Group Co.,Ltd	40.84B
Shanghai Fosun Pharmaceutical (Group)	40.12B
Shenzhen Mindray Bio-Medical Electronics	32.94B
Jiangsu Hengrui Medicine	30.15B
Zhejiang NHU Company	22.87B
Aier Eye Hospital Group	21.94B

Revenue Rankings